TARS CIK: 1819790

Tarsus Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.75
FY22:
−49.0
FY23:
−117
FY24:
−83.0
FY25:
−12.5
Change from FY21 to FY25
millions USD
FY21:
−0.59
FY22:
−145
FY23:
141
FY24:
−199
FY25:
−42.1
Change from FY21 to FY25
millions USD
FY21:
0.02
FY22:
94.0
FY23:
130
FY24:
155
FY25:
143
millions USD
FY21:
3.18
FY22:
−99.7
FY23:
153
FY24:
−128
FY25:
88.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.16
FY22:
−49.5
FY23:
−119
FY24:
−84.6
FY25:
−22.3

All amounts in millions USD Data source:SEC EDGAR